These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9114223)

  • 21. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
    Klaus BD; Grodesky MJ
    Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
    [No Abstract]   [Full Text] [Related]  

  • 22. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
    Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
    Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AmFAR extols FDA on rapid approval of two protease inhibitors.
    AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
    Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
    AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract]   [Full Text] [Related]  

  • 26. Protease inhibitor approved for AIDS treatment.
    AORN J; 1996 Sep; 64(3):453. PubMed ID: 8876926
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxicity. Milk thistle and indinavir.
    TreatmentUpdate; 2002; 14(7):4-5. PubMed ID: 12400499
    [No Abstract]   [Full Text] [Related]  

  • 28. Ingrown toenail and indinavir: case-control study demonstrates strong relationship.
    Bourezane Y; Thalamy B; Viel JF; Bardonnet K; Drobacheff C; Gil H; Vuitton DA; Hoen B
    AIDS; 1999 Oct; 13(15):2181-2. PubMed ID: 10546880
    [No Abstract]   [Full Text] [Related]  

  • 29. Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
    Monpoux F; Sirvent N; Cottalorda J; Mariani R; Lefbvre JC
    AIDS; 1997 Oct; 11(12):1523-5. PubMed ID: 9342078
    [No Abstract]   [Full Text] [Related]  

  • 30. Indinavir nephropathy.
    Tashima KT; Horowitz JD; Rosen S
    N Engl J Med; 1997 Jan; 336(2):138-40. PubMed ID: 8992346
    [No Abstract]   [Full Text] [Related]  

  • 31. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.
    Murphy M; Armstrong D; Sepkowitz KA; Ahkami RN; Myskowski PL
    AIDS; 1997 Feb; 11(2):261-2. PubMed ID: 9030382
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical application of HIV protease inhibitors].
    Chiba N; Shintani M; Ueno T; Hayashi H
    Tanpakushitsu Kakusan Koso; 1998 May; 43(6):744-51. PubMed ID: 9612068
    [No Abstract]   [Full Text] [Related]  

  • 33. Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
    AIDS Patient Care STDS; 1998 Apr; 12(4):315-6. PubMed ID: 11361959
    [No Abstract]   [Full Text] [Related]  

  • 34. Stevens-Johnson syndrome caused by indinavir.
    Teira R; Zubero Z; Muñoz J; Baraia-Etxaburu J; Santamaria JM
    Scand J Infect Dis; 1998; 30(6):634-5. PubMed ID: 10225405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Painful hyperaesthesia caused by protease inhibitors?
    Colebunders R; De Droogh E; Pelgrom Y; Depraetere K; De Jonghe P
    Infection; 1998; 26(4):250-1. PubMed ID: 9717686
    [No Abstract]   [Full Text] [Related]  

  • 36. Switching HIV-1 protease inhibitor therapy: which? When? And why?
    Guardiola JM; Domingo P; Vazquez G
    Arch Intern Med; 1999 Jan; 159(2):194-5. PubMed ID: 9927104
    [No Abstract]   [Full Text] [Related]  

  • 37. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.
    Carr A; Brown D; Cooper DA
    AIDS; 1997 Nov; 11(13):1657-8. PubMed ID: 9365776
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid development of indinavir-induced asymptomatic crystalluria in a human immunodeficiency virus-negative patient.
    Antony SJ
    Clin Infect Dis; 1998 Oct; 27(4):911-2. PubMed ID: 9798063
    [No Abstract]   [Full Text] [Related]  

  • 39. Indinavir-associated toxicity mimicking urinary tuberculosis in a patient with AIDS.
    Delfino VD; Santiago NM; Mocelin AJ; Kunii LF; Bortoliero AL
    Braz J Infect Dis; 2008 Feb; 12(1):99-100. PubMed ID: 18553024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New products and research bring guarded optimism, new questions about AIDS therapy.
    Miller JL
    Am J Health Syst Pharm; 1996 Sep; 53(18):2129-30, 2132. PubMed ID: 8879314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.